Edition:
India

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

547.90INR
23 Jan 2018
Change (% chg)

-- (--)
Prev Close
Rs547.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
66,469
52-wk High
Rs648.00
52-wk Low
Rs469.85

Chart for

About

Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal,... (more)

Overall

Beta: 0.37
Market Cap(Mil.): Rs94,710.40
Shares Outstanding(Mil.): 188.52
Dividend: 4.00
Yield (%): 0.80

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.62
EPS (TTM): -- -- --
ROI: -- 14.89 10.61
ROE: -- 16.37 14.21

BRIEF-Alembic Pharmaceuticals Says U.S. FDA Grants Orphan-Drug Designation To Rhizen Pharmaceuticals

* U.S. FDA GRANTS ORPHAN-DRUG DESIGNATION FOR TENALISIB TO RHIZEN PHARMACEUTICALS S.A. (RHIZEN) Source text - http://bit.ly/2C7DIYd Further company coverage:

26 Dec 2017

BRIEF-Alembic Pharma Gets U.S. FDA Nod For Generic Drug to Treat Overactive Bladder

* DRUG IS INTENDED TO TREAT OVERACTIVE BLADDER Source text: http://bit.ly/2BVyJWK Further company coverage:

12 Dec 2017

MEDIA-India's Alembic Pharma plans greenfield projects to feed global market - Business Line

- Note: Reuters has not verified this story and does not vouch for its accuracy

08 Nov 2017

BRIEF-India's Alembic Pharma Sept-qtr consol PAT rises

* Says U.S. formulations business continues to face price erosion on some key products; India branded business showing signs of recovery‍​‍​

07 Nov 2017

BRIEF-Alembic Pharma buys generic drug developer Orit Laboratories

* Says ‍co buys U.S. based generic drug developer Orit Laboratories LLC​ Source text: http://bit.ly/2z3AKCI Further company coverage:

01 Nov 2017

BRIEF-Alembic Pharmaceuticals gets EU GMP certificate for audit conducted at Panelav

* Alembic Pharmaceuticals - gets EU GMP certificate for audit conducted at its formulation facility at Panelav from 8th to 10th Aug Source text for Eikon: Further company coverage:

31 Aug 2017

BRIEF-Alembic Pharma Ltd says sold Baddi plant to Scott Edil Pharmacia Ltd

* Says sold Baddi, Solan plant to Scott Edil Pharmacia Ltd on slump sale basis

23 Aug 2017

BRIEF-Alembic Pharmaceuticals sells formulations manufacturing facility at Baddi to Scott Edil Pharmacia

* Alembic pharmaceuticals says sold on slump sale basis its formulations manufacturing facility at Baddi, dist. Solan to Scott Edil Pharmacia Limited Source text for Eikon: Further company coverage:

23 Aug 2017

BRIEF-India's Alembic Pharmaceuticals says fire at Algerian JV plant

* Says there was a fire incident at Algerian joint venture plant at Constantine, Algeria Constantine, Algeria

18 Aug 2017

BRIEF-Alembic Pharmaceuticals gets U.S. FDA approval for Doxycycline Capsules USP, 75 mg & 100 mg

* Says Alembic Pharmaceuticals Limited receives USFDA approval for Doxycycline Capsules USP, 75 mg and 100 Mg.

31 Jul 2017

Earnings vs. Estimates